BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26303530)

  • 1. Group IVA Cytosolic Phospholipase A2 Regulates the G2-to-M Transition by Modulating the Activity of Tumor Suppressor SIRT2.
    Movahedi Naini S; Sheridan AM; Force T; Shah JV; Bonventre JV
    Mol Cell Biol; 2015 Nov; 35(21):3768-84. PubMed ID: 26303530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic phospholipase A2α regulates G1 progression through modulating FOXO1 activity.
    Naini SM; Choukroun GJ; Ryan JR; Hentschel DM; Shah JV; Bonventre JV
    FASEB J; 2016 Mar; 30(3):1155-70. PubMed ID: 26644349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation.
    Serrano L; Martínez-Redondo P; Marazuela-Duque A; Vazquez BN; Dooley SJ; Voigt P; Beck DB; Kane-Goldsmith N; Tong Q; Rabanal RM; Fondevila D; Muñoz P; Krüger M; Tischfield JA; Vaquero A
    Genes Dev; 2013 Mar; 27(6):639-53. PubMed ID: 23468428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress.
    Inoue T; Hiratsuka M; Osaki M; Yamada H; Kishimoto I; Yamaguchi S; Nakano S; Katoh M; Ito H; Oshimura M
    Oncogene; 2007 Feb; 26(7):945-57. PubMed ID: 16909107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis.
    North BJ; Verdin E
    PLoS One; 2007 Aug; 2(8):e784. PubMed ID: 17726514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells.
    Yao M; Xie C; Kiang MY; Teng Y; Harman D; Tiffen J; Wang Q; Sved P; Bao S; Witting P; Holst J; Dong Q
    Oncotarget; 2015 Oct; 6(33):34458-74. PubMed ID: 26416244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deacetylation of the mitotic checkpoint protein BubR1 at lysine 250 by SIRT2 and subsequent effects on BubR1 degradation during the prometaphase/anaphase transition.
    Suematsu T; Li Y; Kojima H; Nakajima K; Oshimura M; Inoue T
    Biochem Biophys Res Commun; 2014 Oct; 453(3):588-94. PubMed ID: 25285631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src regulates the activity of SIRT2.
    Choi YH; Kim H; Lee SH; Jin YH; Lee KY
    Biochem Biophys Res Commun; 2014 Jul; 450(2):1120-5. PubMed ID: 24996174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of cytosolic phospholipase A2{alpha} in bronchial mucus hypersecretion in CFTR-deficient mice.
    Dif F; Wu YZ; Burgel PR; Ollero M; Leduc D; Aarbiou J; Borot F; Garcia-Verdugo I; Martin C; Chignard M; Israel-Biet D; Kita Y; Scholte BJ; Touqui L
    Eur Respir J; 2010 Nov; 36(5):1120-30. PubMed ID: 20413542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors.
    Inoue T; Nakayama Y; Li Y; Matsumori H; Takahashi H; Kojima H; Wanibuchi H; Katoh M; Oshimura M
    FEBS J; 2014 Jun; 281(11):2623-37. PubMed ID: 24712640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for cyclin A1 in the activation of MPF and G2-M transition during meiosis of male germ cells in mice.
    Liu D; Liao C; Wolgemuth DJ
    Dev Biol; 2000 Aug; 224(2):388-400. PubMed ID: 10926775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosolic Phospholipase A2 Alpha Regulates TLR Signaling and Migration in Metastatic 4T1 Cells.
    Tunset HM; Feuerherm AJ; Selvik LM; Johansen B; Moestue SA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the G2/M transition by p53.
    Taylor WR; Stark GR
    Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT2 directs the replication stress response through CDK9 deacetylation.
    Zhang H; Park SH; Pantazides BG; Karpiuk O; Warren MD; Hardy CW; Duong DM; Park SJ; Kim HS; Vassilopoulos A; Seyfried NT; Johnsen SA; Gius D; Yu DS
    Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13546-51. PubMed ID: 23898190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NQO1 regulates mitotic progression and response to mitotic stress through modulating SIRT2 activity.
    Kang HJ; Song HY; Ahmed MA; Guo Y; Zhang M; Chen C; Cristofanilli M; Horiuchi D; Vassilopoulos A
    Free Radic Biol Med; 2018 Oct; 126():358-371. PubMed ID: 30114477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ser515 phosphorylation-independent regulation of cytosolic phospholipase A2alpha (cPLA2alpha) by calmodulin-dependent protein kinase: possible interaction with catalytic domain A of cPLA2alpha.
    Shimizu M; Nakamura H; Hirabayashi T; Suganami A; Tamura Y; Murayama T
    Cell Signal; 2008 May; 20(5):815-24. PubMed ID: 18280113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic group IVA and calcium-independent group VIA phospholipase A2s act on distinct phospholipid pools in zymosan-stimulated mouse peritoneal macrophages.
    Gil-de-Gómez L; Astudillo AM; Guijas C; Magrioti V; Kokotos G; Balboa MA; Balsinde J
    J Immunol; 2014 Jan; 192(2):752-62. PubMed ID: 24337743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the role of cytosolic phospholipase A2 alpha in eicosanoid generation and thymocyte maturation in the thymus.
    Rousseau M; Naika GS; Perron J; Jacques F; Gelb MH; Boilard E
    PLoS One; 2015; 10(5):e0126204. PubMed ID: 25969996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells.
    Boutros R; Byrne JA
    Exp Cell Res; 2005 Oct; 310(1):152-65. PubMed ID: 16112108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.
    Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G
    Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.